Background: HER2 targeting in esophageal adenocarcinoma (EAC) has shown potential. but often fails to show durable response. Given the contributions of the tumor immune microenvironment (TIME) to therapeutic responses. we aimed to chart the TIME characteristics of HER2 positive tumors. https://normakamalies.shop/product-category/scent/